Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
James C. Foster
CEOJames C. Foster
Employees
20,100
Employees20,100
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
20,100
Employees20,100

CRL Key Statistics

Market cap
11.16B
Market cap11.16B
Price-Earnings ratio
-145.83
Price-Earnings ratio-145.83
Dividend yield
Dividend yield
Average volume
848.18K
Average volume848.18K
High today
$226.93
High today$226.93
Low today
$220.51
Low today$220.51
Open price
$220.51
Open price$220.51
Volume
499.54K
Volume499.54K
52 Week high
$228.88
52 Week high$228.88
52 Week low
$91.86
52 Week low$91.86

Stock Snapshot

As of today, Charles River(CRL) shares are valued at $226.77. The company's market cap stands at 11.16B, with a P/E ratio of -145.83.

On 2026-01-22, Charles River(CRL) stock moved within a range of $220.51 to $226.93. With shares now at $226.77, the stock is trading +2.8% above its intraday low and -0.1% below the session's peak.

Trading activity shows a volume of 499.54K, compared to an average daily volume of 848.18K.

The stock's 52-week range extends from a low of $91.86 to a high of $228.88.

The stock's 52-week range extends from a low of $91.86 to a high of $228.88.

CRL News

TipRanks 22h
Charles River, Gazi University Faculty of Medicine enter manufacturing pact

Charles River (CRL) and Gazi University Faculty of Medicine announced a gene therapy contract development and manufacturing organization collaboration, providin...

TipRanks 1d
Top Charles River Labs Executive Makes Notable Insider Stock Move

New insider activity at Charles River Labs ( (CRL) ) has taken place on January 20, 2026. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerf...

Simply Wall St 4d
Should Charles River Leadership Shift and M&A Push Reshape Its Innovation-Led Growth Strategy?

In January 2026, Charles River Laboratories announced a planned CEO transition to long-time executive Birgit Girshick, expanded its M&A pipeline, including deal...

Should Charles River Leadership Shift and M&A Push Reshape Its Innovation-Led Growth Strategy?

Analyst ratings

55%

of 20 ratings
Buy
55%
Hold
40%
Sell
5%

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.